Abstract:Aldose Reductase (AR) reduces a variety of substrates, such as aldehydes, aldoses and corticosteroids. It is the first and rate-limiting enzyme of the polyol pathway and is an important target enzyme for diabetes-associated complications, including retinopathy, neuropathy, and nephropathy. Inhibitors targeting this enzyme are structurally different and some of them have side effects. In existing publications, computational techniques are applied to investigate the binding affinities of existing inhibitors and predicting the affinities of newly designed ligands. However, these calculations only employ coarse and approximated methods such as docking and MM/PBSA. Brute force simulations are employed to study the dynamics of the system but no converged statistics is obtained. As a result, these computations provide results not consistent with experimental values and large discrepancies exist. In the current work, we employ the enhanced sampling technique of alchemical free energy simulation to calculate the binding affinities of several ligands targeting AR. The statistical error is defined with care and the correlation in the time-series data is fully considered. The statistically optimal estimators are used to extract the free energy estimates and the predicted results are in agreement with the experimental values. Less computationally demanding end-point free energy methods are also performed to compare their efficiency with the alchemical methods. As is expected, the end-point methods are of less accuracy and reliability compared with the alchemical free energy methods. The decomposition of the free energy difference in each alchemical transformation into the enthalpic and entropic components gives further insights on the thermodynamics. The enthalpy-entropy compensation is observed in this case. As the structural data obtained from experiments are only snapshots and more details are needed to understand the dynamics of the protein-ligand system, the conformational ensemble is analyzed. We identify important residues involved in the protein-ligand binding case and short-lived interactions formed due to fluctuations in the conformational ensemble. The current work shed light on the atomic detailed understanding of the dynamics of AR-inhibitors interactions.

Insights into the Interaction Mechanisms of Estrogen-Related Receptor Alpha (errα) with Ligands Via Molecular Dynamics Simulations

Computational investigation of the interaction mechanism between the estrogen related receptor alpha and its agonists

Computational Insights into the Interaction Mechanisms of Estrogen‐related Receptor Alpha with Endogenous Ligand Cholesterol

Discovery of New Estrogen-Related Receptor α Agonists via a Combination Strategy Based on Shape Screening and Ensemble Docking

Recent advance in the design of small molecular modulators of estrogen-related receptors.

Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.

Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.

Structural Insights into the Specificity of Ligand Binding and Coactivator Assembly by Estrogen-Related Receptor Β

Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.

G Protein-Coupled Estrogen Receptor (Gper) Agonist Dual Binding Mode Analyses Toward Understanding Of Its Activation Mechanism: A Comparative Homology Modeling Approach

Identification of Pyrido[1,2-α]pyrimidine-4-ones As New Molecules Improving the Transcriptional Functions of Estrogen-Related Receptor Α

Understanding Aldose Reductase-Inhibitors interactions with free energy simulation

Evaluation of structural and thermodynamic insight of ERβ with DPN and derivatives through MMGBSA/MMPBSA methods

Agonist And Antagonist Recognition Studies For Oestrogen Receptor By Molecular Dynamics Simulation

LARMD: Integration of Bioinformatic Resources to Profile Ligand-Driven Protein Dynamics with a Case on the Activation of Estrogen Receptor.

ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease

Role of Pocket Flexibility in the Modulation of Estrogen Receptor Alpha by Key Residue Arginine 394.

In Silico Prediction of Estrogen Receptor Subtype Binding Affinity and Selectivity Using 3D-QSAR and Molecular Docking

Asymmetric Allostery in Estrogen Receptor-α Homodimers Drives Responses to the Ensemble of Estrogens in the Hormonal Milieu

Exploring the impact of estrogen-related receptor gamma on metabolism and disease

Computational Insights on Agonist and Antagonist Mechanisms of Estrogen Receptor Α Induced by Bisphenol A Analogues.